Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2

PURPOSE: The growth and survival of neurofibromatosis type 2 (NF2)–deficient cells are enhanced by the activation of multiple signaling pathways including ErbBs/IGF-1R/Met, PI3K/Akt, and Ras/Raf/Mek/Erk1/2. The chaperone protein HSP90 is essential for the stabilization of these signaling molecules....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Cancer Res
Prif Awduron: Tanaka, Karo, Eskin, Ascia, Chareyre, Fabrice, Jessen, Walter J., Manent, Jan, Niwa-Kawakita, Michiko, Chen, Ruihong, White, Cory H., Vitte, Jeremie, Jaffer, Zahara M., Nelson, Stanley F., Rubenstein, Allan E., Giovannini, Marco
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4331126/
https://ncbi.nlm.nih.gov/pubmed/23714726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3167
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg